2023/06/09 18:00:00 | |
---|---|
Price | |
22.203 CHF | |
Difference | 38.56% (6.18) |
ISIN | DE0005664809 |
Symbol | EVT |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3,992 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 21.89 CHF (3,526) |
Ask (Ask size) | 21.928 CHF (3,526) |
Open | 22.333 CHF |
High | 22.333 CHF |
Low | 22.203 CHF |
Close (prev. day) | 16.024 CHF |
VWAP | 22.321182 CHF |
Volume (pcs) | 220 |
Trading volume | 4,910.60 |
Number of trades | 2 |
Last size | 20 |
Related Futures | 23 |
Related Options | - |
Date | Headline | Download | |
2023/06/06 |
![]() |
Global Equity Ratings |
![]() |
2023/06/06 |
![]() |
Aktienempfehlungen Global |
![]() |
2023/06/01 |
![]() |
Aktienempfehlungen Global |
![]() |
2023/06/01 |
![]() |
Global Equity Ratings |
![]() |
2023/05/30 |
![]() |
Aktienempfehlungen Österreich |
![]() |
2023/06/09 18:00:00 | |
---|---|
Price | |
22.203 CHF | |
Difference | 38.56% (6.18) |
ISIN | DE0005664809 |
Symbol | EVT |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3,992 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 21.89 CHF (3,526) |
Ask (Ask size) | 21.928 CHF (3,526) |
Open | 22.333 CHF |
High | 22.333 CHF |
Low | 22.203 CHF |
Close (prev. day) | 16.024 CHF |
VWAP | 22.321182 CHF |
Volume (pcs) | 220 |
Trading volume | 4,910.60 |
Number of trades | 2 |
Last size | 20 |
6M | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 1.03 | 1.13 | 0.86 |
Volatility | 257.73 | 257.73 | 257.73 |
Ø price 5 days | Ø volume 5 days (pcs.) | 17.860 CHF (484) |
Ø price 30 days | Ø volume 30 days (pcs.) | - CHF (386) |
Ø price 100 days | Ø volume 100 days (pcs.) | - CHF (386) |
Ø price 250 days | Ø volume 250 days (pcs.) | - CHF (386) |
YTD High | date | 22.333 CHF (2023/06/09) |
YTD Low | date | 15.812 CHF (2023/05/08) |
52 Weeks High | date | 22.333 CHF (2023/06/09) |
52 Weeks Low | date | 15.812 CHF (2023/05/08) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
BX Swiss | 2023/06/09 | 18:00 | 22.203 CHF | 0.00 | 2 |
Berlin | 2023/06/09 | 21:52 | 22.75 EUR | 0.00 | 19 |
Duesseldorf | 2023/06/09 | 08:23 | 23.38 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2023/06/08 | 20:17 | 25.13 USD | 0.01 | 1 |
Frankfurt | 2023/06/09 | 21:49 | 22.76 EUR | 0.04 | 11 |
Hamburg | 2023/06/09 | 15:16 | 22.50 EUR | 0.02 | 3 |
Hanover | 2023/06/09 | 15:10 | 22.52 EUR | 0.01 | 2 |
London Stock Exchange European Trade Reporting | 2023/06/09 | 17:30 | 22.645 EUR | 0.00 | 1 |
Munich | 2023/06/09 | 21:35 | 22.69 EUR | 0.03 | 6 |
SIX Swiss Exchange | 2023/04/12 | 17:35 | 27.76 CHF | 0.00 | 1 |
Stuttgart | 2023/06/09 | 21:55 | 22.63 EUR | 0.14 | 73 |
Tradegate | 2023/06/09 | 22:26 | 22.88 EUR | 2.85 | 667 |
Vienna Stock Exchange | 2023/06/09 | 17:32 | 22.57 EUR | 0.00 | 2 |
Xetra | 2023/06/09 | 17:36 | 22.56 EUR | 10.71 | 2,362 |
EVOTEC SE |
- - |
Manfred Eigen Campus, Essener Bogen 7 - 22419 Hamburg |
Telefon: +49-40-56081-0 |
Fax: +49-40-56081-222 |
E-mail: info@evotec.com |
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany. |
Werner Lanthaler | Chairman of Managing Board |
Cord Dohrmann | Member of Executive Committee |
Craig Johnstone | Member of Executive Committee |
Matthias Evers | Member of Executive Committee |
Laetitia Rouxel | Member of Executive Committee |
Volker Braun | Member of Executive Committee |
Iris Löw-Friedrich | Chairman of Supervisory Board |
Constanze Ulmer-Eilfort | Member of Supervisory Board |
Elaine Sullivan | Member of Supervisory Board |
Mario Polywka | Member of Supervisory Board |
Camilla Languille | Member of Supervisory Board |
Roland Sackers | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.